{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:28:11Z","timestamp":1787970491091,"version":"build-2784847793"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The hallmarks of cancer include dysregulated metabolism and immune evasion. As a basic way of metabolism, lipid metabolism is reprogrammed for the rapid energy and nutrient supply in the occurrence and development of tumors. Lipid metabolism alterations that occur in the tumor microenvironment (TME) affect the antitumor responses of immune cells and cause immune evasion. Therefore, targeting lipid metabolism in the TME for enhancing the antitumor effect of immune cells is a promising direction for cancer treatment. Cancer nanomedicine has great potential in regulating tumor metabolism and tumor immunity. This review summarizes the nanotechnology-based strategies for lipid metabolism regulation in the TME for enhanced anticancer immune responses.<\/jats:p>","DOI":"10.3389\/fphar.2022.840440","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T17:55:37Z","timestamp":1648403737000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity"],"prefix":"10.3389","volume":"13","author":[{"given":"Bin","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1158\/0008-5472.CAN-08-1060","article-title":"Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses Following Overproduction of Prostaglandin E2 by Tumor Cells In Vivo","volume":"68","author":"Ahmadi","year":"2008","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1344804","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous Lipid Uptake Induces Metabolic and Functional Reprogramming of Tumor-Associated Myeloid-Derived Suppressor Cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles Posed by the Tumor Microenvironment to T Cell Activity: A Case for Synergistic Therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The Cholesterol Metabolite 27 Hydroxycholesterol Facilitates Breast Cancer Metastasis through its Actions on Immune Cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune Escape Mechanisms as a Guide for Cancer Immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbcan.2018.05.002","article-title":"Targeting Cancer's Metabolic Co-dependencies: A Landscape Shaped by Genotype and Tissue Context","volume":"1870","author":"Bi","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20201606","DOI":"10.1084\/jem.20201606","article-title":"Lipid Metabolism and Cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"Bottcher","year":"2018","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid Metabolism in Cancer: New Perspectives and Emerging Mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cel"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15698\/cst2019.01.171","article-title":"Regulation of T Cell Antitumor Immune Response by Tumor Induced Metabolic Stress","volume":"3","author":"Chalmin","year":"2018","journal-title":"Cell Stress"},{"key":"B11","doi-asserted-by":"publisher","first-page":"120187","DOI":"10.1016\/j.biomaterials.2020.120187","article-title":"Metabolic Modulation via mTOR Pathway and Anti-angiogenesis Remodels Tumor Microenvironment Using PD-L1-Targeting Codelivery","volume":"255","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"key":"B12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3389\/fendo.2018.00807","article-title":"Cholesterol and its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment","volume":"9","author":"Chimento","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The Role of Peroxisome Proliferator-Activated Receptors (PPAR) in Immune Responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","article-title":"Acetate Dependence of Tumors","volume":"159","author":"Comerford","year":"2014","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-020-2297-3","article-title":"Lipid Droplets: Platforms with Multiple Functions in Cancer Hallmarks","volume":"11","author":"Cruz","year":"2020","journal-title":"Cell Death Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cancers11040450","article-title":"Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-programmed Cell Death-1 (PD-1) Therapy in Melanoma","volume":"11","author":"Daneshmandi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B17","first-page":"3825","article-title":"Anti-atherosclerotic Effects of LXR\u03b1 Agonist through Induced Conversion of M1 Macrophage to M2","volume":"11","author":"Dou","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.yexcr.2013.03.025","article-title":"On the Role of 25-hydroxycholesterol Synthesis by Glioblastoma Cell Lines. Implications for Chemotactic Monocyte Recruitment","volume":"319","author":"Eibinger","year":"2013","journal-title":"Exp. Cel Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"106339","DOI":"10.1016\/j.prostaglandins.2019.106339","article-title":"PGE2 in Fibrosis and Cancer: Insights into Fibroblast Activation","volume":"143","author":"Elwakeel","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fphar.2018.01230","article-title":"Tumor Microenvironment Targeted Nanotherapy","volume":"9","author":"Fernandes","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory Effect of Tumor Cell-Derived Lactic Acid on Human T Cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"152850","DOI":"10.1016\/j.tox.2021.152850","article-title":"Polystyrene Nanoplastics Dysregulate Lipid Metabolism in Murine Macrophages In Vitro","volume":"458","author":"Florance","year":"2021","journal-title":"Toxicology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1038\/s41467-019-12321-3","article-title":"CAR Exosomes Derived from Effector CAR-T Cells Have Potent Antitumour Effects and Low Toxicity","volume":"10","author":"Fu","year":"2019","journal-title":"Nat. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41467-020-14332-x","article-title":"Impaired Lipid Biosynthesis Hinders Anti-tumor Efficacy of Intratumoral iNKT Cells","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1158\/1078-0432.CCR-13-0122","article-title":"Molecular Pathways: Sterols and Receptor Signaling in Cancer","volume":"20","author":"Gabitova","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","article-title":"Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression","volume":"29","author":"Goossens","year":"2019","journal-title":"Cell Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: the Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12859-019-2734-4","article-title":"Investigation of Lipid Metabolism Dysregulation and the Effects on Immune Microenvironments in Pan-Cancer Using Multiple Omics Data","volume":"20","author":"Hao","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"eaaz6667","DOI":"10.1126\/scitranslmed.aaz6667","article-title":"Combination of Metabolic Intervention and T Cell Therapy Enhances Solid Tumor Immunotherapy","volume":"12","author":"Hao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"775462","DOI":"10.3389\/fcell.2021.775462","article-title":"Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges","volume":"9","author":"Hao","year":"2021","journal-title":"Front. Cel Dev. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid Accumulation and Dendritic Cell Dysfunction in Cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e98772","DOI":"10.15252\/embj.201798772","article-title":"Infiltrative and Drug-Resistant Slow-Cycling Cells Support Metabolic Heterogeneity in Glioblastoma","volume":"37","author":"Hoang-Minh","year":"2018","journal-title":"EMBO J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol Metabolism in Cancer: Mechanisms and Therapeutic Opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7150\/thno.27246","article-title":"Targeting Lipid Metabolism to Overcome EMT-Associated Drug Resistance via Integrin \u03b23\/FAK Pathway and Tumor-Associated Macrophage Repolarization Using Legumain-Activatable Delivery","volume":"9","author":"Jin","year":"2019","journal-title":"Theranostics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer Immunoediting from Immune Surveillance to Immune Escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40820-020-00555-6","article-title":"Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy","volume":"13","author":"Kim","year":"","journal-title":"Nanomicro Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1039\/d1en00145k","article-title":"Exposure to Nano-Polystyrene Induces Metabolic Alteration in Lipid Homeostasis in Caco-2","volume":"8","author":"Kim","year":"","journal-title":"Environ. Sci. Nano"},{"key":"B38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.tem.2017.03.002","article-title":"The Role of Oxysterols in Human Cancer","volume":"28","author":"Kloudova","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The Role of Cholesterol in Cancer","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1073\/pnas.1424355112","article-title":"COX\/mPGES-1\/PGE2 Pathway Depicts an Inflammatory-dependent High-Risk Neuroblastoma Subset","volume":"112","author":"Larsson","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3390\/ijms18122539","article-title":"Prostaglandin E2 in the Regulation of Water Transport in Renal Collecting Ducts","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-018-0568-6","article-title":"Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy for Solid Tumors: Lessons Learned and Strategies for Moving Forward","volume":"11","author":"Li","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/cas.15250","article-title":"Nanomedicine Targets Iron Metabolism for Cancer Therapy","volume":"113","author":"Lin","year":"2021","journal-title":"Cancer Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/10641963.2017.1288740","article-title":"LXR\u03b1 Is Expressed at Higher Levels in Healthy People Compared to Atherosclerosis Patients and its Over-expression Polarizes Macrophages towards an Anti-inflammatory M\u03a62 Phenotype","volume":"40","author":"Liu","year":"2018","journal-title":"Clin. Exp. Hypertens."},{"key":"B45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.it.2021.12.004","article-title":"Tumor Microenvironment Metabolites Directing T Cell Differentiation and Function","volume":"43","author":"Liu","year":"2022","journal-title":"Trends Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cel Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic Reprogramming of Natural Killer Cells in Obesity Limits Antitumor Responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4062\/biomolther.2017.211","article-title":"Oncogene-Driven Metabolic Alterations in Cancer","volume":"26","author":"Min","year":"2018","journal-title":"Biomol. Ther. (Seoul)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"42664","DOI":"10.1074\/jbc.M112.386045","article-title":"Cholesterol and Sphingomyelin Drive Ligand-independent T-Cell Antigen Receptor Nanoclustering","volume":"287","author":"Molnar","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"8298","DOI":"10.3390\/ijms22158298","article-title":"PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases","volume":"22","author":"Monroy-Ramirez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41467-017-00523-6","article-title":"Caspase-1 Cleaves PPAR\u03b3 for Potentiating the Pro-tumor Action of TAMs","volume":"8","author":"Niu","year":"2017","journal-title":"Nat. Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated Macrophages: from Mechanisms to Therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3109\/08820139.2012.695417","article-title":"PGE(2)-driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells","volume":"41","author":"Obermajer","year":"2012","journal-title":"Immunol. Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"E6546","DOI":"10.1073\/pnas.1720113115","article-title":"Fatty Acid Metabolism Complements Glycolysis in the Selective Regulatory T Cell Expansion during Tumor Growth","volume":"115","author":"Pacella","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cel Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/ijms22010433","article-title":"Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions","volume":"22","author":"Peng","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.7150\/thno.39434","article-title":"Tumor Cell-Derived Exosomes home to Their Cells of Origin and Can Be Used as Trojan Horses to Deliver Cancer Drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e000638","DOI":"10.1136\/jitc-2020-000638","article-title":"Enhanced Lipid Biosynthesis in Human Tumor-Induced Macrophages Contributes to Their Protumoral Characteristics","volume":"8","author":"Rabold","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.20130440","article-title":"The Oxysterol-CXCR2 axis Plays a Key Role in the Recruitment of Tumor-Promoting Neutrophils","volume":"210","author":"Raccosta","year":"2013","journal-title":"J. Exp. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering Strategies to Overcome the Current Roadblocks in CAR T Cell Therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The Multifaceted Roles of Fatty Acid Synthesis in Cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1016\/j.bbamcr.2015.09.013","article-title":"Cancer Associated Fibroblasts Transfer Lipids and Proteins to Cancer Cells through Cargo Vesicles Supporting Tumor Growth","volume":"1853","author":"Santi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B63","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmet.2016.10.015","article-title":"Lactate Wreaks Havoc on Tumor-Infiltrating T and NK Cells","volume":"24","author":"Scott","year":"2016","journal-title":"Cel Metab."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1158\/0008-5472.CAN-05-0141","article-title":"Tumor Cyclooxygenase-2\/prostaglandin E2-dependent Promotion of FOXP3 Expression and CD4+ CD25+ T Regulatory Cell Activities in Lung Cancer","volume":"65","author":"Sharma","year":"2005","journal-title":"Cancer Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated Macrophages (TAM) as Major Players of the Cancer-Related Inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/leu.2017.162","article-title":"PPAR-delta Modulates Membrane Cholesterol and Cytokine Signaling in Malignant B Cells","volume":"32","author":"Sun","year":"2018","journal-title":"Leukemia"},{"key":"B68","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41401-020-0424-4","article-title":"Harnessing Nanomedicine to Overcome the Immunosuppressive Tumor Microenvironment","volume":"41","author":"Sun","year":"2020","journal-title":"Acta Pharmacol. Sin"},{"key":"B69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nm.2074","article-title":"Tumor-mediated Liver X Receptor-Alpha Activation Inhibits CC Chemokine Receptor-7 Expression on Dendritic Cells and Dampens Antitumor Responses","volume":"16","author":"Villablanca","year":"2010","journal-title":"Nat. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0300891619868287","article-title":"PGC-1\u03b1 Activator-Induced Fatty Acid Oxidation in Tumor-Infiltrating CTLs Enhances Effects of PD-1 Blockade Therapy in Lung Cancer","volume":"106","author":"Wan","year":"2020","journal-title":"Tumori"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1021\/acs.nanolett.9b00021","article-title":"Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin\/JQ1","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"key":"B72","doi-asserted-by":"publisher","first-page":"605154","DOI":"10.3389\/fonc.2020.605154","article-title":"The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/2326-6066.CIR-19-0261","article-title":"RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis","volume":"8","author":"Wu","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","article-title":"The Gluconeogenic Enzyme PCK1 Phosphorylates INSIG1\/2 for Lipogenesis","volume":"580","author":"Xu","year":"2020","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","article-title":"Potentiating the Antitumour Response of CD8(+) T Cells by Modulating Cholesterol Metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/1099-1492(200011)13:7<377::aid-nbm658>3.0.co;2-e","article-title":"Quantitation by (1)H-NMR of Dolichol, Cholesterol and Choline-Containing Lipids in Extracts of normal and Phathological Thyroid Tissue","volume":"13","author":"Yoshioka","year":"2000","journal-title":"NMR Biomed."},{"key":"B77","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/emboj.2009.6","article-title":"Accumulation of Raft Lipids in T-Cell Plasma Membrane Domains Engaged in TCR Signalling","volume":"28","author":"Zech","year":"2009","journal-title":"EMBO J."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.840440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T17:55:41Z","timestamp":1648403741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.840440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":79,"alternative-id":["10.3389\/fphar.2022.840440"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.840440","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"article-number":"840440"}}